Organoruthenium carbide complexes as precatalysts for olefin metathesis

US11554365B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11554365-B2
Application numberUS-202217677102-A
CountryUS
Kind codeB2
Filing dateFeb 22, 2022
Priority dateSep 18, 2019
Publication dateJan 17, 2023
Grant dateJan 17, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embodiments in accordance with the present invention encompass an organoruthenium compound of the formula (I) or formula (II): Wherein X, L, R 1 , R 2 , R 3 , R 4 , R 5 , Ar 1 and Ar 2 are as defined herein. Also disclosed herein are the use of organoruthenium compound of formula (I) or formula (II) as (pre)catalysts for the olefin metathesis reactions, as well as to the process for carrying out the olefin metathesis reaction.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of formula II: wherein: X is chlorine, bromine or iodine; L is PR 3 , where R is independently selected from the group consisting of isopropyl, sec-butyl, tert-butyl, cyclohexyl, bicyclo(C 5 -C 10 )alkyl, phenyl, benzyl, isopropoxy, sec-butoxy, tert-butoxy, cyclohexyloxy, phenoxy and benzyloxy; R 2 and R 3 are the same or different and each independently selected from the group consisting of hydrogen, methyl, ethyl, linear or branched (C 1 -C 6 )alkyl, (C 6 -C 10 )aryl, methoxy, ethoxy, linear or branched (C 1 -C 6 )alkoxy, (C 6 -C 10 )aryloxy, —NHCO(C 1 -C 6 )alkyl, —NHCO-perfluoro(C 1 -C 6 )alkyl, —SO 2 N((C 1 -C 6 )alkyl) 2 and —NO 2 ; or R 2 and R 3 taken together with the carbon atom to which they are attached to form a (C 3 -C 7 )cycloalkyl ring; R 4 and R 5 are the same or different and each independently selected from the group consisting of hydrogen, methyl, ethyl and linear or branched (C 1 -C 6 )alkyl; Ar 2 is selected from the group consisting of substituted or unsubstituted phenyl, substituted or unsubstituted biphenyl and substituted or unsubstituted naphthyl; wherein said substituents are selected from the group consisting of methyl, ethyl, iso-propyl, tert-butyl and phenyl. 2. The compound according to claim 1 , wherein: X is chlorine or iodine; each R 2 , R 3 , R 4 and R 5 is independently selected from the group consisting of methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, tert-butyl and phenyl; Ar 2 is substituted phenyl; and L is PR 3 , where each R is independently selected from the group consisting of isopropyl, sec-butyl, tert-butyl, cyclohexyl and phenyl. 3. The compound according to claim 1 , wherein: X is chlorine; R 2 and R 3 taken together with the carbon atom to which they are attached to form a cyclopentyl, cyclohexyl or cycloheptyl ring; each R 4 and R 5 is independently selected from the group consisting of hydrogen, methyl, ethyl and iso-propyl; Ar 2 is selected from the group consisting of phenyl, 2-methylphenyl, 2,4-dimethylphenyl, 2,6-dimethylphenyl, 2,4,6-trimethylphenyl, 2-ethylphenyl, 2,4-diethylphenyl, 2,6-diethylphenyl, 2,4,6-triethylphenyl, 2-isopropylphenyl and 2,6-diisopropylphenyl; and L is tri(isopropyl)phosphine or tricyclohexylphosphine. 4. The compound according to claim 1 , wherein: X is chlorine; each R 2 , R 3 , R 4 and R 5 independently is methyl or ethyl; Ar 2 is selected from the group consisting of phenyl, 2,4-dimethylphenyl, 2,6-dimethylphenyl, 2,4,6-trimethylphenyl, 2,4-diethylphenyl, 2,6-diethylphenyl, 2,4,6-triethylphenyl, 2-isopropylphenyl and 2,6-diisopropylphenyl; and L is tricyclohexylphosphine. 5. The compound according to claim 1 , wherein: X is iodine; each R 2 , R 3 , R 4 and R 5 independently is methyl or ethyl; Ar 2 is selected from the group consisting of 2,6-dimethylphenyl, 2,4,6-trimethylphenyl, 2,6-diethylphenyl, 2,4,6-triethylphenyl and 2,6-diisopropylphenyl; and L is tricyclohexylphosphine. 6. The compound according to claim 1 , which is: 1-(2,6-diethylphenyl)-3,3,5,5-tetramethylpyrrolidin-2-ylidene-triisopropylphosphine ruthenium carbide dichloride. 7. The compound according to claim 1 , which is: 1-(2,6-diisopropylphenyl)-3,3,5,5-tetramethylpyrrolidin-2-ylidene-triisopropylphosphine ruthenium carbide dichloride. 8. The compound according to claim 1 , which is: 1-(2,6-diethylphenyl)-3,3,5,5-tetramethylpyrrolidin-2-ylidene-triisopropylphosphine ruthenium carbide diiodide. 9. The compound according to claim 1 , which is: 1-(2,6-diethylphenyl)-3,3,5,5-tetramethylpyrrolidin-2-ylidene-triisopropylphosphine ruthenium carbide diiodide. 10. The compound according to claim 1 , which is: 1-(2,6-diisopropylphenyl)-3,3-dimethyl-2λ 2 -azaspiro[4.5]decylidene-triisopropylphosphine ruthenium carbide dichloride. 11. The compound according to claim 1 , which is: 1-(2,6-diisopropylphenyl)-3,3-dimethyl-2λ 2 -azaspiro[4.5]decylidene-triisopropylphosphine ruthenium carbide diiodide. 12. The compound according to claim 1 , which is: 1-(2,6-diethylphenyl)-3,5,5-trimethyl-3-phenylpyrrolidin-2-ylidene-triisopropylphosphine ruthenium carbide dichloride. 13. The compound according to claim 1 , which is: 1-(2,6-diethylphenyl)-3,5,5-trimethyl-3-phenylpyrrolidin-2-ylidene-triisopropylphosphine ruthenium carbide diiodide. 14. A process for carrying out a metathesis reaction of olefins, comprising contacting at least one olefin with the compound of claim 1 as a precatalyst. 15. The process according to claim 14 , wherein the metathesis reaction is carried out in an organic solvent. 16. The process according to claim 15 , wherein the organic solvent is selected from the group consisting of dichloromethane, dichloroethane, toluene, ethyl acetate and a mixture in any combination thereof. 17. The process according to claim 14 , wherein the metathesis reaction is carried out in the presence of a chemical activator. 18. The process according to claim 17 , wherein the chemical activator is a Bronsted or Lewis acid or a halo-derivative of alkane or silane. 19. The process according to claim 14 , wherein the metathesis reaction is carried out in the presence of a photoacid generator. 20. The process according to claim 14 , wherein the metathesis reaction is carried out in the presence of a thermal acid generator.

Assignees

Inventors

Classifications

  • Quaternary phosphonium groups · CPC title

  • Ruthenium compounds · CPC title

  • Complexes comprising two carbene ligands differing from each other, e.g. Grubbs second generation catalysts · CPC title

  • with only hydrogen or carbon atoms directly attached to the ring nitrogen atom · CPC title

  • Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11554365B2 cover?
Embodiments in accordance with the present invention encompass an organoruthenium compound of the formula (I) or formula (II): Wherein X, L, R 1 , R 2 , R 3 , R 4 , R 5 , Ar 1 and Ar 2 are as defined herein. Also disclosed herein are the use of organoruthenium compound of formula (I) or formula (II) as (pre)catalysts for the olefin metathesis reactions, as well as t…
Who is the assignee on this patent?
Apeiron Synthesis Sa, Promerus Llc
What technology area does this patent fall under?
Primary CPC classification C07F15/0046. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).